ATAI ATAI Life Sciences NV
Price (delayed)
$1.47
Market cap
$291.51M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.93
Enterprise value
$298.71M
Highlights
ATAI's quick ratio has dropped by 68% year-on-year and by 47% since the previous quarter
The equity has dropped by 52% year-on-year and by 20% since the previous quarter
Key stats
What are the main financial stats of ATAI
Market
Valuations
Earnings
Shares outstanding
198.31M
Market cap
$291.51M
Enterprise value
$298.71M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.12
Price to sales (P/S)
764.4
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
969.84
Revenue
$308,000
Gross profit
$308,000
Operating income
-$102.69M
Net income
-$149.27M
EBIT
-$146.5M
EBITDA
-$145.61M
Free cash flow
-$82.45M
Per share
Balance sheet
Liquidity
EPS
-$0.93
EPS diluted
-$0.93
Free cash flow per share
-$0.51
Book value per share
$0.69
Revenue per share
$0
TBVPS
$0.97
Total assets
$159.39M
Total liabilities
$42.83M
Debt
$24.71M
Equity
$116.3M
Working capital
$55.17M
Debt to equity
0.21
Current ratio
3.21
Quick ratio
2.9
Net debt/EBITDA
-0.05
Margins
Efficiency
Dividend
EBITDA margin
-47,276.6%
Gross margin
100%
Net margin
-48,464%
Operating margin
-33,341.2%
Return on assets
-70.9%
Return on equity
-91.5%
Return on invested capital
-76.7%
Return on capital employed
-109%
Return on sales
-47,565.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ATAI stock price
How has the ATAI Life Sciences stock price performed over time
Intraday
3.52%
1 week
21.49%
1 month
0.68%
1 year
-25.76%
YTD
10.53%
QTD
8.09%
Financial performance
How have ATAI Life Sciences's revenue and profit performed over time
Revenue
$308,000
Gross profit
$308,000
Operating income
-$102.69M
Net income
-$149.27M
Gross margin
100%
Net margin
-48,464%
The net margin has declined by 25% since the previous quarter
ATAI Life Sciences's operating income has increased by 18% YoY and by 3.1% from the previous quarter
ATAI Life Sciences's operating margin has increased by 17% YoY but it has decreased by 4.1% from the previous quarter
The net income has contracted by 16% from the previous quarter
Growth
What is ATAI Life Sciences's growth rate over time
Valuation
What is ATAI Life Sciences stock price valuation
P/E
N/A
P/B
2.12
P/S
764.4
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
969.84
ATAI's EPS is down by 16% since the previous quarter
The equity has dropped by 52% year-on-year and by 20% since the previous quarter
The P/B is 41% more than the last 4 quarters average of 1.5
ATAI Life Sciences's revenue has decreased by 7% QoQ
ATAI's P/S is 3.7% above its last 4 quarters average of 737.2
Efficiency
How efficient is ATAI Life Sciences business performance
The company's return on equity fell by 39% QoQ
ATAI's ROA is down by 35% since the previous quarter
The company's return on invested capital fell by 33% QoQ
ATAI's ROS is down by 25% since the previous quarter
Dividends
What is ATAI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ATAI.
Financial health
How did ATAI Life Sciences financials performed over time
ATAI's quick ratio has dropped by 68% year-on-year and by 47% since the previous quarter
The current ratio has plunged by 65% YoY and by 45% from the previous quarter
The debt is 79% smaller than the equity
The company's debt to equity has surged by 163% YoY and by 31% QoQ
The equity has dropped by 52% year-on-year and by 20% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.